SEARCH

Current Edition

alder

Alder BioPharmaceuticals® to Host Conference Call to Discuss Second Quarter 2018 Financial and Operating Results

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that it will report its …

Continue Reading →